Actively Recruiting
Optimization of Radiation Protection Through Genomic Analyses
Led by University Hospital, Essen · Updated on 2024-09-27
30
Participants Needed
1
Research Sites
293 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The long-term goal is to define "signatures" in the form of genomic changes through sequence analyses of genomic DNA using modern Next Generation Sequencing (NGS) methods, which 1. determine the radiation exposure of humans. 2. provide information about the exposure (dose). 3. determine the radiation quality. 4. predict the repair capacity and radiation resistance of an individual.
CONDITIONS
Official Title
Optimization of Radiation Protection Through Genomic Analyses
Who Can Participate
Eligibility Criteria
You may qualify if you...
- ECOG performance status 0 or 1
- No prior cancer diagnosis
- No prior treatment including chemotherapy, radiotherapy, immunotherapy, or targeted therapy
- Diagnosed with thoracic or head and neck cancer
You will not qualify if you...
- Any prior treatment such as chemotherapy, radiotherapy, immunotherapy, or targeted therapy
- Any previous cancer diagnosis
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Department for Radiotherapy, University Hospital Essen, National Center for Tumor Diseases (NCT) West
Essen, Germany / NRW, Germany, 45147
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
BASIC_SCIENCE
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here